Get more replies from employers
Send a job-specific resume in minutes.
Protagonist Therapeutics is seeking an Associate Director/Director, Program Management to lead and coordinate activities advancing a program from Ph1 through Ph3. You will work with project teams and stakeholders to shape strategy and drive timelines, budgets, and decision points.
The role requires 10+ years in program management within biopharma, strong collaboration, and hands-on execution. On-site at our Newark, CA office, with travel as needed.
Protagonist Therapeutics is a discovery-through-late-stage development biopharmaceutical company with a proprietary technology platform that enables de novo discovery of peptide therapeutics. Two novel peptides derived from Protagonist's proprietary discovery platform are at or near commercialization. ICOTYDE™ (icotrokinra), licensed to Johnson & Johnson company Janssen Biotech, Inc., is the first and only targeted oral peptide that precisely blocks the Interleukin-23 receptor. ICOTYDE was launched in the U.S. in March 2026, is approved for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age or older and is in Phase 3 development for psoriatic arthritis, ulcerative colitis and Crohn's disease. ICOTYDE was jointly discovered by Protagonist and Johnson & Johnson scientists, with Protagonist having primary responsibility for the development of ICOTYDE through Phase 1, and Johnson & Johnson assuming responsibility for further development and commercialization. Protagonist also discovered and led development through Phase 3 of rusfertide, a first-in-class hepcidin mimetic peptide licensed to Takeda Pharmaceuticals. An NDA for rusfertide for the treatment of polycythemia vera is under priority review with the FDA. The Company also has a number of clinical and preclinical programs addressing clinically and commercially validated targets, including an oral IL-17 antagonist peptide, obesity dual and triple agonists, an oral hepcidin functional mimetic, and the recently announced IL-4 and amylin programs.
More information on Protagonist, its pipeline drug candidates, and clinical studies can be found on the Company's website at https://www.protagonist-inc.com.
The Associate Director/Director, Program Management is a critical function and will be responsible for leading and coordinating all activities associated with advancing a program through Ph1 to Ph3 clinical trials. The individual will be a key member of project teams, working closely with the stakeholders and contribute to the definition of project strategy and guide the project and functional teams to deliver on program and corporate objectives. This position will be accountable for steering core teams through internal processes and manage the integration of preclinical, clinical, cmc, and regulatory execution. Develop and ensure timely execution of complex project plans, as well as manage project timelines, budget to achieve key milestones and timely decision points.
The base pay range for this position at commencement of employment is expected to be between $175,000 and $225,000/year; however, base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience.
A top priority for Protagonist Therapeutics, Inc. is to provide a robust and comprehensive health and wellness program for our employees and their families. We offer a variety of high-quality coverage and benefit options.